Insilico's Lung Drug Reverses Aging Markers in Study

Insilico Medicine reported that a lung drug discovered through artificial intelligence showed reversal of biological aging markers in a study. Alex Zhavoronkov, the company's founder and CEO, commented on the findings. Bloomberg reported on the development.

Next story